Security key
90042W100
Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX)
CUSIP: 90042W100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 23,142,592
- Total 13F shares
- 12,701,832
- Share change
- -655,709
- Total reported value
- $33,279,598
- Price per share
- $2.62
- Number of holders
- 45
- Value change
- -$1,718,315
- Number of buys
- 25
- Number of sells
- 22
Report period
Q2 2024
Institutions
45
Top holders
10
TSBX full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Turnstone Biologics Corp. SEC filings
Turnstone Biologics Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90042W100
Recent filing periods:
Top shareholders of TSBX - Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
13%
|
3,099,265
|
$8,120,074 | — | 31 Mar 2024 | |
| FMR LLC |
13F
3/4/5
|
Company · Other* |
6.8%
|
1,574,826
|
$4,126,044 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
5.1%
|
1,183,888
|
$3,101,787 | — | 31 Mar 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
4%
|
920,976
|
$2,412,957 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
3.9%
|
899,373
|
$2,356,357 | — | 31 Mar 2024 | |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
3.9%
|
895,824
|
$2,347,060 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3%
|
684,837
|
$1,794,272 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
663,404
|
$1,738,119 | — | 31 Mar 2024 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
2.4%
|
549,981
|
$1,440,950 | — | 31 Mar 2024 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
2.2%
|
517,648
|
$1,356,238 | — | 31 Mar 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2%
|
458,317
|
$1,200,791 | — | 31 Mar 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
1.6%
|
369,780
|
$969,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
369,676
|
$968,551 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
238,084
|
$623,826 | — | 31 Mar 2024 | |
| FIL Ltd |
13F
|
Company |
0.83%
|
192,657
|
$504,761 | — | 31 Mar 2024 | |
| Zimmer Partners, LP |
13F
|
Company |
0.77%
|
179,026
|
$469,048 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.52%
|
121,381
|
$318,018 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.43%
|
99,475
|
$260,624 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
59,900
|
$156,938 | — | 31 Mar 2024 | |
| Kathleen S. Wright Associates Inc. |
13F
|
Company |
0.18%
|
42,553
|
$111,489 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.17%
|
38,491
|
$100,846 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
34,443
|
$90,241 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.14%
|
32,746
|
$85,795 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
23,594
|
$61,816 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
23,371
|
$61,232 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
19,057
|
$49,929 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.08%
|
18,842
|
$49,366 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
9,109
|
$23,858 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.03%
|
7,616
|
$19,954 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
6,170
|
$16,165 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
5,013
|
$13,134 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,409
|
$8,932 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
2,939
|
$7,700 | — | 31 Mar 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
1,755
|
$4,598 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
796
|
$2,105 | — | 31 Mar 2024 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
630
|
$1,651 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
346
|
$1,000 | — | 31 Mar 2024 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
205
|
$1,000 | — | 31 Mar 2024 | |
| Avion Wealth |
13F
|
Company |
0%
|
178
|
$1,000 | — | 31 Mar 2024 | |
| NISA INVESTMENT ADVISORS, LLC |
13F
|
Company |
0%
|
30
|
$79 | — | 31 Mar 2024 | |
| Sammy J. Farah |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
155,321
|
— | — | 16 Oct 2023 | |
| Saryah Azmat |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
56,637
|
— | — | 16 Oct 2023 | |
| Venkat Ramanan |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
46,606
|
— | — | 16 Oct 2023 | |
| Stewart Abbot |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
45,542
|
— | — | 16 Oct 2023 | |
| P. Joseph Campisi Jr. |
3/4/5
|
Chief Legal Officer |
—
class O/S missing
|
44,377
|
— | — | 16 Oct 2023 | |
| Kanya Rajangam |
3/4/5
|
Director |
—
class O/S missing
|
12,770
|
— | — | 03 Jun 2024 | |
| Robert J. Gould |
3/4/5
|
Director |
—
class O/S missing
|
12,770
|
— | — | 03 Jun 2024 | |
| William D. Waddill |
3/4/5
|
Director |
—
class O/S missing
|
12,770
|
— | — | 03 Jun 2024 | |
| Michael F. Burgess |
3/4/5
|
Interim Chief Medical Officer, Director |
—
class O/S missing
|
11,464
|
— | — | 16 Oct 2023 |
Institutional Holders of Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) as of Q2 2024
As of 30 Jun 2024,
Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,701,832 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, Point72 Asset Management, L.P., PFM Health Sciences, LP, BANK OF AMERICA CORP /DE/, TAKEDA PHARMACEUTICAL CO LTD, CITADEL ADVISORS LLC, VANGUARD GROUP INC, 72 Investment Holdings, LLC, and SECTORAL ASSET MANAGEMENT INC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
40
Q2 2024 holders
45
Holder diff
5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.